Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Case Report

Published on 28 Nov 2024

Case Report: Efficacy of anlotinib and sintilimab in treating lung adenocarcinoma with RET fusion and PD-L1 expression

in Pharmacology of Anti-Cancer Drugs

Hejing Bao
Jiani Zhang
Yuhuan Wang
Zhiting Chen
Xi Luo
Ting Li
Haoran Su
Hehong Bao
Xiaolong Cao
Liping Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1448291

1,149 views
1 citation

Original Research

Published on 28 Nov 2024

Cepharanthine as an effective small cell lung cancer inhibitor: integrated insights from network pharmacology, RNA sequencing, and experimental validation

in Pharmacology of Anti-Cancer Drugs

Fengyun Zhao
Zhaowei Ding
Mengting Chen
Mingfang Ji
Fugui Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1517386

1,857 views

Systematic Review

Published on 27 Nov 2024

Ubiquitin-specific peptidases in lymphoma: a path to novel therapeutics

in Pharmacology of Anti-Cancer Drugs

Maryam Samareh Salavatipour
Shirin Tavakoli
Aram Halimi
Shima Tavoosi
Amir-Hossein Baghsheikhi
Abdolkarim Talebi-Taheri
Mehdi Niloufari
Zahra Salehi
Javad Verdi
Soheila Rahgozar

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1356634

1,475 views

Original Research

Published on 27 Nov 2024

Anti-tumor and anti-metastatic effects of RRx-001 on hepatocellular carcinoma: mechanisms of action and therapeutic potential

in Pharmacology of Anti-Cancer Drugs

Guohong Yan
Shuqi Zhao
Meifeng Chen
Shutian Mo
Hailian Huang
Yuan Liao
Ziyan Lu
Jiaming Liang
Shuxin Wei
Chuangye Han

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1469825

1,569 views

Editorial

Published on 27 Nov 2024

Editorial: Utilizing omics strategies to discover new drug targets for cancers

in Pharmacology of Anti-Cancer Drugs

Shujun Zhang
Chen Xue
Xinyu Gu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1526976

802 views

Editorial

Published on 26 Nov 2024

Editorial: Exploring immunotherapy targets and strategies for cancer: a multi-omics perspective

in Pharmacology of Anti-Cancer Drugs

Wanchun Nie
Kailin Tang
Lu Xie
Tianyi Qiu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1506444

625 views

Original Research

Published on 26 Nov 2024

Role of anoikis-related gene RAC3 in prognosis, immune microenvironment, and contribution to malignant behavior in vitro and in vivo of bladder urothelial carcinoma

in Pharmacology of Anti-Cancer Drugs

Yusong Zhou
Shiwei Huang
Bing Yang
Jing Tan
Zhun Zhang
Wei Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503623

1,095 views

Original Research

Published on 25 Nov 2024

Bufonis venenum extract loaded novel cholesterol-free liposome for the treatment of hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Siqi Yang
Jinshuai Lan
Zhe Li
Ming Li
Ya Wu
Liyan Sun
Tong Zhang
Yue Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1486742

1,161 views

Systematic Review

Published on 21 Nov 2024

Efficacy and safety of anti-angiogenic drugs combined with chemotherapy in the treatment of platinum-sensitive/resistant ovarian cancer: a meta-analysis with trial sequential analysis of randomized controlled trials

in Pharmacology of Anti-Cancer Drugs

Haining He
Fei Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1446403

1,354 views

Original Research

Published on 21 Nov 2024

The role of epigenetic regulation in pancreatic ductal adenocarcinoma progression and drug response: an integrative genomic and pharmacological prognostic prediction model

in Pharmacology of Anti-Cancer Drugs

Kang Fu
Junzhe Su
Yiming Zhou
Xiaotong Chen
Xiao Hu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1498031

2,281 views
1 citation

Original Research

Published on 19 Nov 2024

Targeting autophagy: polydatin’s role in inducing cell death in AML

in Pharmacology of Anti-Cancer Drugs

Ping Fu
Qing Luo
Chao Wang
Liping Chen
Chang Dong
Ke Yang
Guang Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1470217

1,229 views
3 citations

Original Research

Published on 19 Nov 2024

Impact of camel milk lactoferrin peptides against breast cancer cells: in silico and in vitro study

in Pharmacology of Anti-Cancer Drugs

Othman Baothman
Ehab M. M. Ali
Hassan Alguridi
Salman Hosawi
Emadeldin Hassan E. Konozy
Isam M. Abu Zeid
Abrar Ahmad
Hisham N. Altayb

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1425504

2,359 views
1 citation

Methods

Published on 18 Nov 2024

Protocol of REACH-01: a single-arm, open label, prospective study of HAIC sequential TAE combined with tislelizumab and surufatinib in unresectable intrahepatic cholangiocarcinoma

in Pharmacology of Anti-Cancer Drugs

Kang-shuai Li
Yi Liu
Tie-zhong Zhang
Yun-fei Xu
Zong-li Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1435639

2,263 views

Original Research

Published on 18 Nov 2024

Maslinic acid induces autophagy and ferroptosis via transcriptomic and metabolomic reprogramming in prostate cancer cells

in Pharmacology of Anti-Cancer Drugs

Fen Hu
Yuxi Sun
Yunfeng Zhang
Jiaxin Chen
Yingzi Deng
Yifei Li
Ruobing Li
Juan Zhang
Yongping Liang
Yan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1453447

2,519 views

Correction

Published on 14 Nov 2024

Corrigendum: Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer

in Pharmacology of Anti-Cancer Drugs

Hui-Wen Yang
Yan Lan
An Li
Han Wu
Zi-Wei Song
Ai-Ling Wan
Yue Wang
Shi-Bao Li
Shuai Ji
Zhong-Cheng Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1447095

728 views

Review

Published on 13 Nov 2024

Natural products: promising therapeutics for targeting regulatory immune cells in the tumor microenvironment

in Pharmacology of Anti-Cancer Drugs

Peng Song
Fei Song
Tingting Shao
Pengjuan Wang
Rongkun Li
Zhe-Sheng Chen
Zhaofang Zhang
Guozhong Xue

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1481850

1,754 views